Retrospective study on timing of resection of hepatocellular adenoma
British Journal of Surgery Sep 02, 2017
Klompenhouwer AJ, et al. – As per present guidelines, management of hepatocellular adenoma includes cessation of oral contraceptives and surgical resection if the lesion is still larger than 5 cm at 6 months after diagnosis. Researchers aimed at evaluating whether this 6–month interval is sufficient to expect regression of a large Hepatocellular adenoma (HCA) to 5 cm or smaller. Findings indicate that a 6–month cut–off point for assessment of regression of HCA larger than 5 cm to no more than 5 cm is too early. They identify no documentation regarding complications during follow–up, the cut–off point in women with typical, non–β–catenin–activated HCA could be prolonged to 12 months, irrespective of baseline diameter.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries